Tanda BioTech

Tanda BioTech is a private bioprocess equipment company specializing in automated, low-volume tangential flow filtration (TFF) systems. Its core innovation is the TxFlow™ Go, a benchtop instrument that dramatically reduces minimum working volume, hold-up volume, and setup time compared to traditional methods, targeting research and early-stage process development. The company leverages this platform to offer custom, scaled-up integrated systems for manufacturing, with experience in projects like COVID-19 vaccine production. Backed by grants like the NSF SBIR, Tanda is positioned as a tool provider enabling more efficient and reproducible bioprocessing for therapeutic developers.

Automated Tangential Flow Filtration (TFF) systems for low-volume bioprocessing, featuring the TxFlow™ platform with ultra-low hold-up volume, walk-away automation, and scalable design from benchtop (TxFlow™ Go) to custom integrated manufacturing systems.

Tanda competes in the bioprocess filtration market against dominant integrated players like Cytiva (ÄKTA flux), Sartorius, and Repligen, as well as specialized TFF companies. Its primary competitive edge is a dedicated focus on automation and ease-of-use at the sub-milliliter scale, a segment often underserved by larger players focused on larger process volumes. It also competes with manual methods like dialysis and centrifugal concentrators by offering superior reproducibility and hands-off operation.